Results 311 to 320 of about 199,785 (356)

Neutralizing antibody responses to the primary series of a COVID-19 mRNA vaccine in the cancer cohort under active treatment. [PDF]

Hum Vaccin Immunother
Xue H, Kemp TJ, Li C, Roche NV, Bakouny Z, Labaki C, Lee GM, Trowbridge R, Strauss S, Hughes ME, Lin NU, Choueiri TK, Pinto LA.   +12 more
europepmc   +1 more source

Effectiveness of a Covid mRNA Vaccine Against Two Early Variants: A Reanalysis of Published Data. [PDF]

Cureus
Shahar E.
europepmc   +1 more source

Developing an eVLP mRNA vaccine for respiratory syncytial virus with enhanced pre-fusion targeting humoral responses. [PDF]

J Virol
Sun L, Huang M, Feng S, Zhang W, Quan Y, Chen R, Yang Y, Xu H, Li W, Pan Q, Chen X, Zhang D, Yuan B, Zhao J, Wang Z, Lin J, Peng W, Ludlow M, Zhang Q.   +18 more
europepmc   +1 more source

Rational design and in silico characterization of a multiepitope mRNA vaccine candidate against human metapneumovirus (hMPV) using reverse vaccinology and immunoinformatics approaches. [PDF]

Sci Rep
Izhari MA, Gosady ARA, Alghamdi F, Alghamdi WA, Hadadi MAA, Almontasheri AHA, Dardari DMM, Salem AA, Alotaibi FE.   +8 more
europepmc   +1 more source

Flagellin co-expression potentiates mRNA vaccine-induced cytotoxic T lymphocyte responses but not anti-tumor immunity. [PDF]

Sci Rep
Li Y, Kang X, Song Y, Akter L, VanLuinen E, Nakkala JR, Chen X.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

mRNA vaccines

Nature Biotechnology, 2021
The concept of developing mRNA as vaccine platform evolved over the last decades. mRNA uses host cells for antigen production, can induce B and T cell responses and does not rely on unwanted antigens that may interfere with booster doses like vector vaccines.
openaire   +3 more sources

Innate sensing of mRNA vaccines

Current Opinion in Immunology, 2022
With the recent success of mRNA vaccines and the approval of several RNA oligonucleotide therapeutics, RNA holds great promise for future drug development. The rise of RNA therapeutics has been enabled by the tremendous progress in our understanding of the sophisticated cellular mechanisms that disarm potentially dangerous exogenous RNA and safeguard ...
Christine, Wuebben, Eva, Bartok, Gunther, Hartmann   +2 more
openaire   +2 more sources

mRNA Cancer Vaccines

2016
mRNA cancer vaccines are a relatively new class of vaccines, which combine the potential of mRNA to encode for almost any protein with an excellent safety profile and a flexible production process. The most straightforward use of mRNA vaccines in oncologic settings is the immunization of patients with mRNA vaccines encoding tumor-associated antigens ...
Katja, Fiedler, Sandra, Lazzaro, Johannes, Lutz, Susanne, Rauch, Regina, Heidenreich   +4 more
openaire   +2 more sources